Literature DB >> 24778034

miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung.

Hark Kyun Kim, Na Jung Lim, Sang-Geun Jang, Geon Kook Lee.   

Abstract

BACKGROUND/AIM: Distinguishing between primary and metastatic adenocarcinomas in the lung may sometimes be difficult by conventional histopathological methods. In addition, novel biomarkers are needed for the more accurate subtyping of primary lung carcinomas.
MATERIALS AND METHODS: MicroRNA microarrays were performed on 26 primary lung adenocarcinomas, 3 squamous cell carcinomas, 6 small cell lung cancers (SCLCs), and 2 colorectal cancer metastases in the lung.
RESULTS: Forty-four microRNAs differentially expressed between three histological subtypes at p<10(-6) predicted histology with 100% accuracy in 100 randomly drawn datasets. Prominent among differentially expressed genes were miR-375, miR-217 and miR-216a, which were found overexpressed in SCLC compared to lung adenocarcinomas. Lung adenocarcinomas overexpressed miR-29b-1, miR-375, miR-2110, miR-29c-star, 199b-5p, and 146b-3p and underexpressed miR-617, miR-205-star, and miR-1246 compared to squamous cell carcinomas. In primary vs. metastatic lung adenocarcinomas, miR-552 and miR-592 were differentially expressed at p<10(-6); the level of expression of miR-552 in colorectal cancer metastases was 39-times higher and that of miR-592 was six-times higher. Furthermore, microRNA profiles of primary colorectal cancer in our database indicated that these two microRNAs were overexpressed in primary colorectal cancer relative to primary lung adenocarcinomas.
CONCLUSION: MicroRNA profiles predict the histology of primary lung carcinomas, and differentiate between primary lung adenocarcinomas and colorectal cancer metastases.

Entities:  

Keywords:  MicroRNA; differential diagnosis; lung adenocarcinoma; metastasis

Mesh:

Substances:

Year:  2014        PMID: 24778034

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  MiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression.

Authors:  Zhehui Liu; Ruiqin Wu; Guanzeng Li; Peng Sun; Qinghua Xu; Zhimin Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics.

Authors:  Rong Wang; Xiao-Feng Chen; Yong-Qian Shu
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Construction and analysis of three networks of genes and microRNAs in adenocarcinoma.

Authors:  Jiahui Ning; Xiaoxin Guo; Ning Wang; Luchen Xue
Journal:  Oncol Lett       Date:  2015-09-03       Impact factor: 2.967

4.  MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.

Authors:  Jia Cao; Xiu-Rui Yan; Ting Liu; Xue-Bo Han; Jing-Jing Yu; Shi-Hai Liu; Li-Bin Wang
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

Review 5.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

6.  Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.

Authors:  Qing-Yong Chen; De-Min Jiao; Ya Zhu; Huizhen Hu; Jian Wang; Xiali Tang; Jun Chen; Li Yan
Journal:  Tumour Biol       Date:  2015-08-01

Review 7.  MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.

Authors:  Jian Wang; Yong Du; Xiaoming Liu; William C Cho; Yinxue Yang
Journal:  Biomed Res Int       Date:  2015-05-06       Impact factor: 3.411

8.  MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway.

Authors:  Yuguo Zhao; Jianwen Zhang; Wenbin Yang; Zhao Yang; Kaikai Zhou
Journal:  J Oncol       Date:  2021-05-04       Impact factor: 4.375

Review 9.  MicroRNAs: Clinical Relevance in Colorectal Cancer.

Authors:  Joe Thomas; Masahisa Ohtsuka; Martin Pichler; Hui Ling
Journal:  Int J Mol Sci       Date:  2015-11-25       Impact factor: 5.923

10.  MicroRNAs expression profile in solid and unicystic ameloblastomas.

Authors:  A Setién-Olarra; X Marichalar-Mendia; N G Bediaga; P Aguirre-Echebarria; J M Aguirre-Urizar; A Mosqueda-Taylor
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.